These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 19766383)
1. Editorial comment on: characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Thalmann G Eur Urol; 2010 Feb; 57(2):309. PubMed ID: 19766383 [No Abstract] [Full Text] [Related]
2. Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9. Ponholzer A; Madersbacher S Eur Urol; 2010 Jul; 58(1):e9. PubMed ID: 20346579 [No Abstract] [Full Text] [Related]
3. Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9. Papatsoris AG; Mitsogiannis I; Deliveliotis C Eur Urol; 2010 Aug; 58(2):e19. PubMed ID: 20004053 [No Abstract] [Full Text] [Related]
4. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Masood S; Mufti GR Urology; 2008 Oct; 72(4):952; author reply 952. PubMed ID: 18926256 [No Abstract] [Full Text] [Related]
6. Editorial comment to The clinical significance of urine cytology after a radical cystectomy for urothelial cancer. Ukimura O Int J Urol; 2010 Jun; 17(6):532-3. PubMed ID: 20482664 [No Abstract] [Full Text] [Related]
7. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059 [TBL] [Abstract][Full Text] [Related]
8. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. Dutta SC; Smith JA; Shappell SB; Coffey CS; Chang SS; Cookson MS J Urol; 2001 Aug; 166(2):490-3. PubMed ID: 11458053 [TBL] [Abstract][Full Text] [Related]
9. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup. Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294 [TBL] [Abstract][Full Text] [Related]
16. Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Montgomery JS; Weizer AZ; Montie JE Urology; 2011 Mar; 77(3):667-8. PubMed ID: 21377013 [No Abstract] [Full Text] [Related]
17. Determining the role of cystectomy for high-grade T1 urothelial carcinoma. Daneshmand S Urol Clin North Am; 2013 May; 40(2):233-47. PubMed ID: 23540781 [TBL] [Abstract][Full Text] [Related]
18. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631 [TBL] [Abstract][Full Text] [Related]
19. Cancer specific outcomes in patients with pT0 disease following radical cystectomy. Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Lotan Y; Vazina A; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; J Urol; 2006 May; 175(5):1645-9; discussion 1649. PubMed ID: 16600721 [TBL] [Abstract][Full Text] [Related]
20. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]